Cargando…
Comparative Efficacy of Topical Finasteride (0.25%) in Combination with Minoxidil (5%) Against 5% Minoxidil or 0.25% Finasteride Alone in Male Androgenetic Alopecia: A Pilot, Randomized Open-Label Study
BACKGROUND: Androgenetic alopecia (AGA) is the most common cause of hair loss in males which remains a therapeutic challenge. OBJECTIVES: To compare the efficacy of topical 5% minoxidil and 0.25% finasteride combination (MNF) over 5% minoxidil (MNX) or 0.25% finasteride (FNS) alone by assessing hair...
Autores principales: | Bharadwaj, Apoorva V, Mendiratta, Vibhu, Rehan, Harmeet Singh, Tripathi, Smita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495069/ https://www.ncbi.nlm.nih.gov/pubmed/37701551 http://dx.doi.org/10.4103/ijt.ijt_72_22 |
Ejemplares similares
-
Real-World Effectiveness, Safety, and Tolerability of Cetosomal Minoxidil 5% Alone and a Fixed Drug Combination of Cetosomal Minoxidil 5% With Finasteride 0.1% in the Management of Androgenetic Alopecia (Inbilt Study)
por: Kerure, Amit, et al.
Publicado: (2023) -
Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil(®), Finasteride(®), and Adult Stem Cell-Based Therapy
por: Gentile, Pietro, et al.
Publicado: (2020) -
Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride
por: Chandrashekar, B. S., et al.
Publicado: (2015) -
New Target for Minoxidil in the Treatment of Androgenetic Alopecia
por: Shen, Yuqing, et al.
Publicado: (2023) -
A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia
por: Shah, Kaksha B, et al.
Publicado: (2017)